IBDEI04A ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1662,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1662,1,4,0)
 ;;=4^436.
 ;;^UTILITY(U,$J,358.3,1662,1,5,0)
 ;;=5^CVA
 ;;^UTILITY(U,$J,358.3,1662,2)
 ;;=^2710
 ;;^UTILITY(U,$J,358.3,1663,0)
 ;;=246.9^^11^137^20
 ;;^UTILITY(U,$J,358.3,1663,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1663,1,4,0)
 ;;=4^246.9
 ;;^UTILITY(U,$J,358.3,1663,1,5,0)
 ;;=5^Thyroid Disorder NOS
 ;;^UTILITY(U,$J,358.3,1663,2)
 ;;=^123878
 ;;^UTILITY(U,$J,358.3,1664,0)
 ;;=345.90^^11^137^8
 ;;^UTILITY(U,$J,358.3,1664,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1664,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,1664,1,5,0)
 ;;=5^Epilep NOS w/o Intr Epil
 ;;^UTILITY(U,$J,358.3,1664,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,1665,0)
 ;;=578.9^^11^137^11
 ;;^UTILITY(U,$J,358.3,1665,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1665,1,4,0)
 ;;=4^578.9
 ;;^UTILITY(U,$J,358.3,1665,1,5,0)
 ;;=5^Gastrointest Hemorr NOS
 ;;^UTILITY(U,$J,358.3,1665,2)
 ;;=^49525
 ;;^UTILITY(U,$J,358.3,1666,0)
 ;;=784.0^^11^137^12
 ;;^UTILITY(U,$J,358.3,1666,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1666,1,4,0)
 ;;=4^784.0
 ;;^UTILITY(U,$J,358.3,1666,1,5,0)
 ;;=5^Headache
 ;;^UTILITY(U,$J,358.3,1666,2)
 ;;=^7044423
 ;;^UTILITY(U,$J,358.3,1667,0)
 ;;=861.01^^11^137^13
 ;;^UTILITY(U,$J,358.3,1667,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1667,1,4,0)
 ;;=4^861.01
 ;;^UTILITY(U,$J,358.3,1667,1,5,0)
 ;;=5^Heart Contusion,Closed
 ;;^UTILITY(U,$J,358.3,1667,2)
 ;;=^274738
 ;;^UTILITY(U,$J,358.3,1668,0)
 ;;=V15.81^^11^137^14
 ;;^UTILITY(U,$J,358.3,1668,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1668,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,1668,1,5,0)
 ;;=5^Hx of Past Noncompliance
 ;;^UTILITY(U,$J,358.3,1668,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,1669,0)
 ;;=783.21^^11^137^22
 ;;^UTILITY(U,$J,358.3,1669,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1669,1,4,0)
 ;;=4^783.21
 ;;^UTILITY(U,$J,358.3,1669,1,5,0)
 ;;=5^Weight Loss
 ;;^UTILITY(U,$J,358.3,1669,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,1670,0)
 ;;=340.^^11^137^16
 ;;^UTILITY(U,$J,358.3,1670,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1670,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,1670,1,5,0)
 ;;=5^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,1670,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,1671,0)
 ;;=278.01^^11^137^17
 ;;^UTILITY(U,$J,358.3,1671,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1671,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,1671,1,5,0)
 ;;=5^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,1671,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,1672,0)
 ;;=278.00^^11^137^18
 ;;^UTILITY(U,$J,358.3,1672,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1672,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,1672,1,5,0)
 ;;=5^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,1672,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,1673,0)
 ;;=V65.5^^11^137^19
 ;;^UTILITY(U,$J,358.3,1673,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1673,1,4,0)
 ;;=4^V65.5
 ;;^UTILITY(U,$J,358.3,1673,1,5,0)
 ;;=5^Person w/ Feared Complaint,No Dx
 ;;^UTILITY(U,$J,358.3,1673,2)
 ;;=^295564
 ;;^UTILITY(U,$J,358.3,1674,0)
 ;;=266.9^^11^137^21
 ;;^UTILITY(U,$J,358.3,1674,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1674,1,4,0)
 ;;=4^266.9
 ;;^UTILITY(U,$J,358.3,1674,1,5,0)
 ;;=5^Vitamin B Deficiency NOS
 ;;^UTILITY(U,$J,358.3,1674,2)
 ;;=^126956
 ;;^UTILITY(U,$J,358.3,1675,0)
 ;;=V70.7^^11^138^1
 ;;^UTILITY(U,$J,358.3,1675,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1675,1,4,0)
 ;;=4^V70.7
 ;;^UTILITY(U,$J,358.3,1675,1,5,0)
 ;;=5^Exam in Clinical Trial
 ;;^UTILITY(U,$J,358.3,1675,2)
 ;;=^295597
 ;;^UTILITY(U,$J,358.3,1676,0)
 ;;=369.4^^11^139^4
 ;;^UTILITY(U,$J,358.3,1676,1,0)
 ;;=^358.31IA^5^2
